Vascular Access Thrombosis

PHILADELPHIA — Patients with chronic kidney disease on dialysis who received daprodustat had fewer vascular access thrombosis events compared with patients who had erythropoiesis-stimulating agents, according to data presented here.

Nephrologists and the kidney care team need to improve efforts at educating patients about dialysis.

WASHINGTON — Research presented at ASN Kidney Week suggested that use of a tool that measures clot stiffness could help monitor patients on dialysis for vascular access complications.